Lilly is investing $3 billion to expand its recently acquired manufacturing facility in Wisconsin, while Amgen is investing $1 billion to expand its facility in North Carolina.

Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...

Most experience exists for sitagliptin (Merck) and vildagliptin (Novartis), which both have a long duration of action, allowing once-daily administration. In drug-naïve subjects with type 2 ...

However, with repeated use of the drug, the circuit adjusts to the drug’s effect, reducing sensitivity and making it hard to receive other forms of pleasurable stimulation. When drugs are introduced ...

Apellis is expecting decisions on the drug form regulators in the UK, Switzerland, Canada, and Australia early next year. Researchers have called for action to safeguard the independence of ...

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...

Treatment of these mice with a truncated, soluble form of RAGE (sRAGE), which includes ... null mice that received the same dose and lot of drug as other mice studied, but did not develop ...

But while most of the world is busy trying to keep their children away from marijuana, cocaine, and heroin, another form of drug is gradually taking over their lives. It’s no secret that today’s world ...

From Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Victoria, Australia (R.H.R.) Division of Endocrinology and Metabolism (E.D.A.), ...